X-ray-Fluorescence Imaging for In Vivo Detection of Gold-Nanoparticle-Labeled Immune Cells: A GEANT4 Based Feasibility Study

The growing field of cellular therapies in regenerative medicine and oncology calls for more refined diagnostic tools that are able to investigate and monitor the function and success of said therapies. X-ray Fluorescence Imaging (XFI) can be applied for molecular imaging with nanoparticles, such as...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Arthur Ungerer, Theresa Staufer, Oliver Schmutzler, Christian Körnig, Kai Rothkamm, Florian Grüner
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
XFI
Acceso en línea:https://doaj.org/article/83f6cd08b999442384ffa2d85373a468
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:The growing field of cellular therapies in regenerative medicine and oncology calls for more refined diagnostic tools that are able to investigate and monitor the function and success of said therapies. X-ray Fluorescence Imaging (XFI) can be applied for molecular imaging with nanoparticles, such as gold nanoparticles (GNPs), which can be used in immune cell tracking. We present a Monte Carlo simulation study on the sensitivity of detection and associated radiation dose estimations in an idealized setup of XFI in human-sized objects. Our findings demonstrate the practicability of XFI in human-sized objects, as immune cell tracking with a minimum detection limit of 4.4 × 10<sup>5</sup> cells or 0.86 μg gold in a cubic volume of 1.78 mm<sup>3</sup> can be achieved. Therefore, our results show that the current technological developments form a good basis for high sensitivity XFI.